Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceCombined Modality TherapyMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteTreatment OutcomeImmunosuppressive AgentsRemission InductionHematologic NeoplasmsGraft RejectionBone RemodelingTime FactorsHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow NeoplasmsFibrous Dysplasia of BoneTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidImmunosuppressionLymphocyte DepletionStem Cell TransplantationLeukocyte TransfusionLymphoma, Non-HodgkinAcute DiseaseHeart TransplantationRetrospective StudiesSevere Combined ImmunodeficiencyMyelodysplastic SyndromesChimeraColony-Forming Units AssayT-LymphocytesSurvival AnalysisHLA AntigensLung TransplantationBone DensityCyclosporineActuarial AnalysisHematologic DiseasesLymphocyte TransfusionEctodermal DysplasiaNuclear FamilyFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsCarmustineOrgan TransplantationCell DifferentiationPancytopeniaGraft vs Tumor EffectSurvival RateGraft vs Leukemia EffectLeukocyte CountBronchopulmonary DysplasiaCytarabineCytomegalovirus InfectionsBone ResorptionSpleenGranulocyte Colony-Stimulating FactorMelphalanMice, Inbred BALB CBone Diseases, DevelopmentalDisease-Free SurvivalEtoposideFlow CytometryLymphomaMultiple MyelomaFatal OutcomeCells, CulturedPrognosisMice, KnockoutAntigens, CD34Hodgkin Disease